Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value

NIAGEN BIOSCIENCE, INC. (NAGE) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value of $20.00 thousand for the 12-month period ending 2017-12-30, per its 10-K filed 2019-03-07.

Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree

us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 · last filed 2019-03-07

  • NIAGEN BIOSCIENCE, INC. business combination, step acquisition, equity interest in acquiree, fair value for the quarter ending 2017-12-30 was $0.00.
  • NIAGEN BIOSCIENCE, INC. business combination, step acquisition, equity interest in acquiree, fair value for the quarter ending 2017-09-30 was $0.00.
  • NIAGEN BIOSCIENCE, INC. business combination, step acquisition, equity interest in acquiree, fair value for the quarter ending 2017-07-01 was $0.00.
  • NIAGEN BIOSCIENCE, INC. business combination, step acquisition, equity interest in acquiree, fair value for the quarter ending 2017-04-01 was $20.00K.
  • NIAGEN BIOSCIENCE, INC. business combination, step acquisition, equity interest in acquiree, fair value for fiscal 2017 was $20.00K.
Period endBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 3 monthBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 6 monthBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 9 monthBusiness Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value 12 month
2017-12-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$0.00
derived: sum of 2 quarters · filed 2019-03-07
$0.00
derived: sum of 3 quarters · filed 2019-03-07
$20.00K
10-K · filed 2019-03-07
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$0.00
derived: sum of 2 quarters · filed 2017-11-09
$20.00K
10-Q · filed 2017-11-09
2017-07-01$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$20.00K
10-Q · filed 2017-08-10
2017-04-01$20.00K
10-Q · filed 2017-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87